Skip to content

Effects of an ACT-based Psychological Treatment in Patients With Chronic Kidney Disease

Effects of an ACT-based Psychological Treatment in Patients With Chronic Kidney Disease

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06109493
Enrollment
104
Registered
2023-10-31
Start date
2023-11-01
Completion date
2026-06-30
Last updated
2025-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Kidney Diseases, Depression

Brief summary

Investigation of the efficacy of Acceptance and Commitment Therapy (ACT) for the psychological treatment of patients with chronic kidney disease.

Detailed description

After being informed about the study, all patients giving written informed consent will be assessed to determine eligibility for study entry. The clinical trial will include a control group (waiting list). Patients who meet eligibility requirements will be assigned to control group or intervention group. Psychological intervention will consist in an 8-session individual face-to-face delivered ACT-based treatment. The participants will be assessed through self-report instruments before and after treatment and at 3 months follow-up.

Interventions

BEHAVIORALACT

Acceptance and Commitment Therapy methods were focused on promoting Values clarification, Acceptance, Cognitive defusion, Committed action and Flexible attention to the present moment, and included methods such as the Garden Metaphor, Funeral exercise or Mindfulness training.

Sponsors

Fundación Renal Iñigo Alvarez De Toledo
CollaboratorOTHER
Centro de Enseñanza Superior Cardenal Cisneros
CollaboratorUNKNOWN
Universidad Europea de Madrid
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Masking description

Participants did not know that two different treatments were delivered.

Intervention model description

Randomization assigned participants to 2 arms: * ACT group * Waiting list

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients with chronic kidney disease on haemodialysis * Older than 18 years-old * At least 3 months on haemodialysis * HADS Global Scale Score ≥14

Exclusion criteria

* Diagnosis of severe or chronic mental disorder, mental retardation and cognitive impairment, or disabling illness. * Antidepressant drugs consume * Insufficient understanding of Spanish. * Patients who are in the Advanced Chronic Kidney Disease Unit * Receiving other psychological treatment

Design outcomes

Primary

MeasureTime frameDescription
Change in emotional distress assessed through Hospital Anxiety and Depression Scale (HADS)Change from Baseline Emotional Distress at 5 monthsHADS assesses anxiety, depression and emotional distress. It is a 14-item four-point Likert-type scale. Scores range between 0 and 42. Higher the score in the overall score indicate higher levels of emotional distress and worse outcome.

Secondary

MeasureTime frameDescription
Change in Simplified Medication Adherence Questionnaire (SMAQ)Change from Baseline Adherence at 5 monthsSMAQ assesses adherence to medication. It is a 6-item questionnaire that evaluates different aspects of patient compliance with treatment: forgetfulness, routine, adverse effects, and omissions. A patient is classified as non-compliant if he/she responds to any of the questions with a non-adherence answer, and in terms of quantification, if the patient has lost more than two doses during the last week or has not taken medication during more than two complete days during the last three months.
Change in COOP/WONCA questionnaireChange from Baseline health related Quality of Life at 5 monthsCOOP/WONCA assesses health related Quality of Life (HRQOL). It was selected the 7-item five-point Likert-type version of the scale. Scores range between 0 and 35. Higher scores indicate lower levels of HRQOL and worse outcome.
Change in Acceptance and Action Questionnaire in the context of Haemodialysis (CAAH-II)Change from Baseline psychological inflexibility at 5 monthsAcceptance and Action Questionnaire' assesses psychological inflexibility. It is a 7-item, seven-point Likert-type scale. Scores range between 7 and 49. Higher scores indicate higher levels of psychological inflexibility and worse outcome.
Change in coping skills assessed through coping strategies inventory -short form (CSI-SF)Change from Baseline coping strategies at 5 monthsCSI-SF is a 15-item, five-point Likert-type scale which includes four subscales: Problem Focused Engagement (PFE), Problem Focused Disengagement (PFD), Emotion Focused Engagement (EFE) and Emotion Focused Disengagement (EFD).
Change in mood assessed through Daylio AppChange from Baseline mood at 5 monthsDaylio is a mobile app which allows daily assessing mood through emoticons which will be transformed into a five-point Likert-type scale. Scores range between 1 and 5. Higher scores indicate higher better mood and better outcome.

Countries

Spain

Contacts

Primary ContactFrancisco Montesinos, Ph.D.
francisco.montesinos@universidadeuropea.es+34647413773

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026